Targets? We don't need no stinkin' targets: Tigers' pitchers no longer aim for the glove
In an evolution of the mechanics of baseball, pitchers today visualize tunnels more than the smaller targets like the catcher’s glove.
Yadier Molina talks family, future manager aspirations and his absence from St. Louis
Molina remains hopeful about making a trip to Busch Stadium some time this year, but his family schedule is the priority.
Each MLB team's best roster last 25 years: NL Central
We've reached the quarter mark of the 2000s, and to celebrate, theScore's MLB editors constructed each organization's best 26 ...
Major League Baseball3d
A Cards fan growing up, Maton signs 1-year deal to join childhood team
Coming off one of the best years of his career, right-handed reliever Phil Maton was admittedly taken aback this offseason ...
Yadier Molina makes Cubs admission that will make Cardinals fans sick
Cardinals legend Yadier Molina wants to be a manager so badly he would even do it with the hated Chicago Cubs.
Worthy: There's a lot to like about the Cardinals keeping their top arms in starting roles
If the Cardinals use their top pitching prospects exclusively as starters, it should be a big benefit to their big picture.
Have the Cubs ever played in Japan? Taking a look at their international series History
The Cubs are no strangers to playing internationally. With their series taking place in Tokyo next week, let's take a look at ...
How Matthew Liberatore captures 'resetting' Cardinals' tug-of-war between future and now
"He is on a mission. And you can tell," said manager Oliver Marmol after Liberatore, a current reliever with rotation upside, continued his perfect start to spring.
Every MLB Franchise's Greatest Starting Pitchers of the Last 25 Years
Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Bought by AlphaQuest LLC
AlphaQuest LLC boosted its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) by 2,637.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 15,222 shares of ...
HC Wainwright Reiterates Buy Rating for Mineralys Therapeutics (NASDAQ:MLYS)
HC Wainwright restated their buy rating on shares of Mineralys Therapeutics (NASDAQ:MLYS – Free Report) in a report issued on Monday morning,Benzinga reports. The firm currently has a $30.00 price ...